Any current/future capex/capital investment/strategic investment?

Capacity expansion is underway for tissue culture plants, especially banana and papaya plants, with plans to increase capacity as current capacity until next May has been fully booked by farmers paying advances. The tissue culture business, currently around INR225 crores, is expected to double to INR500 crores in the next 3-4 years, and grow to INR1,000 crores over 5-7 years. These tissue culture plant sales are synergistic, as they drive drip irrigation and pipe sales alongside. No specific mention of inorganic strategic investments; however, the focus remains on managing growth organic

Any current/future new fundraising through debt or equity?

There is no current inorganic transaction or new fundraising for debt or equity on the drawing board as per management's comments (Page 8). The company plans to reduce debt aggressively through free cash flow from operations rather than new borrowings or equity issuance (Page 8). Any rights issue or other means of drastic debt reduction are speculative and not being considered currently (Page 7). Management is focused on deleveraging the company annually and expects to reduce net debt further over the next 12 to 18 months via business performance and cash flow generation (Pages 8-9). There is

Future growth expectations in sales/revenue/volumes?

Stand-alone India business revenue grew about 33% in the first half of the year and is expected to maintain this growth rate for the remainder of the year. Overall consolidated revenue growth is projected around 25% for the full year, with possible upside. The food business is expected to grow about 20% in FY '25, following a recovery year in FY '24. The tissue culture business aims to double from INR225 crores to INR500 crores in the next few years and reach INR1,000 crores over 5-7 years. Plastic business, including overseas segments, is performing well and expected to maintain growt

Future growth expectations in earnings/operating earnings/profits/EPS?

Jain Irrigation expects continued strong revenue growth, with standalone India business growing ~33% in H1 FY24 and maintaining that rate. Consolidated revenue growth is projected around 25%-26%, with potential upside in H2. EBITDA guidance is INR900 to INR1,000 crores for the year, indicating 40%-45% growth compared to prior periods. Historical EBITDA split is about 1/3 in H1 and 2/3 in H2, shifting somewhat closer to 40%-60% currently. Food business EBITDA is expected to grow by 20% in FY25, building on a turnaround to INR240-250 crores EBITDA in FY24. Improvement in operating cash flow is a

Current/ Expected Orderbook/ Pending Orders?

Current consolidated order book: approximately INR 2,000 crores. Stand-alone India business order book: around INR 800 crores. Most stand-alone orders relate to government contracts and some institutional orders (PE pipe business). Dealer business operates on a weekly order supply cycle, maintaining about 10-15 days of orders on hand. Food business overseas subsidiaries hold annual contracts for mangoes and onions, contributing to the order book. Government-related orders in stand-alone India business expected to be executed by March 2025. Majority of outstanding receivables and order backlog

Jain IrrigationQ2 FY24Industrial Products

Jain Irrigation Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹27.3Market Cap: ₹2.1K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Stand-alone India business revenue grew about 33% in the first half of the year and is expected to maintain this growth rate for the remainder of the year.
Overall consolidated revenue growth is projected around 25% for the full year, with possible upside.
The food business is expected to grow about 20% in FY '25, following a recovery year in FY '24.
The tissue culture business aims to double from INR225 crores to INR500 crores in the next few years and reach INR1,000 crores over 5-7 years.
Plastic business, including overseas segments, is performing well and expected to maintain growth and profitability.
The company anticipates continued robust demand in pipe and drip irrigation segments supported by strong dealer networks.
Exports via partners like Rivulis are picking up, targeting over $30 million exports next year.
The focus remains on executing current strategies effectively while managing working capital and reducing debt to support sustainable growth.

Margin guidance

Category 3

Jain Irrigation expects continued strong revenue growth, with standalone India business growing ~33% in H1 FY24 and maintaining that rate.
Consolidated revenue growth is projected around 25%-26%, with potential upside in H2.
EBITDA guidance is INR900 to INR1,000 crores for the year, indicating 40%-45% growth compared to prior periods.
Historical EBITDA split is about 1/3 in H1 and 2/3 in H2, shifting somewhat closer to 40%-60% currently.
Food business EBITDA is expected to grow by 20% in FY25, building on a turnaround to INR240-250 crores EBITDA in FY24.
Improvement in operating cash flow is anticipated in H2 FY24, with better working capital management driving cash conversion.
Leverage is targeted to reduce from 4x to approximately 2.5x net debt to EBITDA within 12 months, improving financial health.
Dividend payments expected in future after debt reduction and growth stabilization.

See what Jain Irrigation management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no current inorganic transaction or new fundraising for debt or equity on the drawing board as per management's comments (Page 8).
The company plans to reduce debt aggressively through free cash flow from operations rather than new borrowings or equity issuance (Page 8).
Any rights issue or other means of drastic debt reduction are speculative and not being considered currently (Page 7).
Management is focused on deleveraging the company annually and expects to reduce net debt further over the next 12 to 18 months via business performance and cash flow generation (Pages 8-9).
There is no mention of any upcoming equity fundraising or major debt raising plans in the presented discussion.

Order book

Current consolidated order book: approximately INR 2,000 crores.
Stand-alone India business order book: around INR 800 crores.
Most stand-alone orders relate to government contracts and some institutional orders (PE pipe business).
Dealer business operates on a weekly order supply cycle, maintaining about 10-15 days of orders on hand.
Food business overseas subsidiaries hold annual contracts for mangoes and onions, contributing to the order book.
Government-related orders in stand-alone India business expected to be executed by March 2025.
Majority of outstanding receivables and order backlog linked to government and project-related contracts.
Secondary sales and dealer stocking strategies are being implemented to maintain order flow and momentum.

See what Jain Irrigation management said on order book — free account, 30 seconds.

Capex plans

Yes

Capacity expansion is underway for tissue culture plants, especially banana and papaya plants, with plans to increase capacity as current capacity until next May has been fully booked by farmers paying advances.
The tissue culture business, currently around INR225 crores, is expected to double to INR500 crores in the next 3-4 years, and grow to INR1,000 crores over 5-7 years.
These tissue culture plant sales are synergistic, as they drive drip irrigation and pipe sales alongside.
No specific mention of inorganic strategic investments; however, the focus remains on managing growth organically, improving working capital, and reducing debt.
Emphasis is on prudent use of cash flows generated to further reduce debt rather than aggressive inorganic expansion at this time.

Track Jain Irrigation — get its next earnings analysis in your feed

How does Jain Irrigation rank vs peers in Industrial Products?

Pro feature

ThisJain Irrigation

Rev 2Mar 3

See where Jain Irrigation sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Jain Irrigation rank in Industrial Products?

Compare Jain Irrigation against every Industrial Products company (Q2 FY24) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What Jain Irrigation's management said in earlier quarters

Others in Industrial Products this season

Monolithisch India Ltd (Q2 FY27)
Combined additional capacity: 3 lakh MT per annum; total capex approximately INR 45 crores. Key concall takeaways from Monolithisch India Ltd's Q2 FY27…
Systematic Industries Ltd (Q1 FY27)
Year-on-Year (YoY) Growth for Q4 Net Sales:** 6.0% . Key concall takeaways from Systematic Industries Ltd's Q1 FY27 earnings call — and how it ranks against…
Graphite India Ltd (Q3 FY24)
690 crore, down 1.6% y-o-y (Page 5, 9) . Key concall takeaways from Graphite India Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
Graphite India Ltd (Q4 FY24)
720 Cr, down 11.7% y-o-y (Page 4, 9) . Key concall takeaways from Graphite India Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

Compare:vs Polycab India Ltd vs Welspun Corp Ltd vs APL Apollo Tubes

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →